This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
25 Oct 2025

BFS-Hyoscin 40mg/2ml (Scopolamine butylbromide 20 mg/ml - Solution for injection)

Composition



Hyoscine butylbromide 40mg/2ml


Dosage Form




Solution for injection




Indication



The relief of acute genitourinary or gastrointestinal spasm (e.g., renal or biliary colic), or to produce smooth muscle relaxation prior to radiological procedures such as pyelography or other diagnostic procedures where spasm may be a problem (e.g., gastro-duodenal endoscopy).


Dosage Adminstration





Adults:One ampoule (40 mg) intramuscularly or intravenously, repeated after half an hour if necessary. Intravenous injection should be performed 'slowly' (in rare cases a marked drop in blood pressure and even shock may be produced by Buscopan). When used in endoscopy this dose may need to be repeated more frequently.Maximum daily dose of 100mg.




Elderly: No specific information on the use of this product in the elderly is available. Clinical trials have included patients over 65 years and no adverse reactions specific to this age group have been reported.




Paediatric population: Not recommended for children.




Hyoscin should not be taken on a continuous daily basis or for extended periods without investigating the cause of abdominal pain.




Diluent: Hyoscin may be diluted with dextrose or with sodium chloride 0.9% injection solutions.

Mentioned Companies
Ha Noi CPC1 Pharmaceutical Joint Stock Company
View company profile